Related Experiment Videos
[Conservative management of ectopic pregnancy]
A Lui1, G D'Ottavio, M A Rustico
1Divisione di Ostetricia e Ginecologia, Istituto per l'Infanzia, IRCCS, Trieste.
Minerva Ginecologica
|March 1, 1997
Summary
Conservative management for ectopic pregnancy, including methotrexate or expectant care, shows high success rates. Expectant management achieved 100% resolution without surgery, highlighting its potential efficacy.
Area of Science:
- Reproductive Medicine
- Gynecology
- Medical Management
Background:
- Ectopic pregnancy management requires careful consideration of safety and efficacy.
- Conservative approaches are being increasingly explored for tubal ectopic pregnancies.
- This study retrospectively analyzes conservative management strategies.
Purpose of the Study:
- To evaluate the safety and efficacy of conservative management for tubal ectopic pregnancy.
- To compare methotrexate injection versus expectant management.
- To identify prognostic factors for successful resolution.
Main Methods:
- Retrospective analysis of 35 women with tubal ectopic pregnancy (1990-1995).
- Inclusion criteria: tubal diameter < 3 cm, free fluid < 100 ml, no embryo heart activity, stable hemodynamics.
- Treatment groups: intramuscular methotrexate (n=18) or expectant management (n=17).
Main Results:
- Methotrexate group: 89% resolution rate, 2 cases required surgery.
- Expectant management group: 100% spontaneous resolution, no surgery needed.
- Average resolution time was approximately 17 days in both groups.
- Initial serum hCG-beta levels and trends were key prognostic indicators.
Conclusions:
- Conservative management, particularly expectant care, demonstrates high efficacy in selected ectopic pregnancy cases.
- Further research is necessary to understand the long-term impact on fertility.
- Serum hCG-beta monitoring is crucial for predicting outcomes.